CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice
6 affiliations
- 1Vascular and Interventional Radiology Department, Cardarelli Hospital, Naples, Italy
- 2Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
- 3Vascular and Interventional Radiology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ramón y Cajal University Hospital, Madrid, Spain
- 4University Hospitals Dorset, Bournemouth, Poole, UK
- 5Cardarelli Hospital, Naples, Italy
- 6Department of Vascular and Interventional Radiology, Université Bourgogne Europe, François-Mitterrand University Hospital, Dijon, France
Abstract
Background: Non-sclerosant liquid embolic agents are safe and effective embolics that have been used in interventional radiology for more than 50 years, in both emergency and elective scenarios.
Purpose: This document aims to review the chemical principles and technical considerations involved, to make recommendations regarding clinical indications for the use of non-sclerosant liquid embolic agents, and to review the literature regarding outcomes and complications. CIRSE Standards of Practice documents are not intended to impose a standard of clinical patient care, but to recommend a reasonable approach to, and best practices for, procedural performance, in this instance the use of non-sclerosant liquid embolic agents.
Methods: The writing group was established by the CIRSE Standards of Practice Committee and consisted of five clinicians with internationally recognised expertise in non-sclerosant liquid embolic agents and a research assistant (P.R.). The writing group reviewed the existing literature on non-sclerosant liquid embolic agents, performing a pragmatic evidence search using PUBMED and EMBASE focussing on English-language publications, preferably from 2009 up to December 2025, and including more than ten patients. Where clear gaps were evident, older literature was searched and select references included. The final recommendations were formulated through consensus.
Results: Non-sclerosant liquid embolic agents are represented by cyanoacrylates and polymers which are safe and effective agents that can be used in a wide range of clinical scenarios, resulting in effective embolization even in patients with impaired coagulation function. Knowing their chemical properties provides understanding of their correct preparation, technical application and clinical indication. Compared to mechanical and particulate agents, non-sclerosant liquid embolic agents present a steeper learning curve, and thus, thorough training in their use is essential.
Related
- Middle Meningeal Artery Embolization Using Non-Adhesive Liquid Embolic Agents for Chronic Resistant Migraine: Interim Feasibility and Safety Analysis of a Prospective Single-Arm Trial
- Feasibility, safety, and efficacy of the amber peripheral liquid embolic system: results from stage I of the first-in-human OPAL study
- Good Clinical Practice standards impact: the essential role of investigator capabilities
- Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards
- Pelvic vein embolization using different embolic agents for the treatment of pelvic venous insufficiency: A systematic review and meta-analysis
BibTeX
@article{giurazza2026cirse,
title = {{CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice}},
author = {Francesco Giurazza and Anna Maria Ierardi and José Urbano and Clare Bent and Pietro Roccatagliata and Romaric Loffroy},
journal = {Cardiovascular and Interventional Radiology},
year = {2026},
month = sep,
doi = {10.1007/s00270-026-04610-4},
url = {https://doi.org/10.1007/s00270-026-04610-4},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice
AU - Francesco Giurazza
AU - Anna Maria Ierardi
AU - José Urbano
AU - Clare Bent
AU - Pietro Roccatagliata
AU - Romaric Loffroy
PY - 2026
DA - 2026/09/23
JO - Cardiovascular and Interventional Radiology
DO - 10.1007/s00270-026-04610-4
UR - https://doi.org/10.1007/s00270-026-04610-4
AB - Background: Non-sclerosant liquid embolic agents are safe and effective embolics that have been used in interventional radiology for more than 50 years, in both emergency and elective scenarios. Purpose: This document aims to review the chemical principles and technical considerations involved, to make recommendations regarding clinical indications for the use of non-sclerosant liquid embolic agents, and to review the literature regarding outcomes and complications. CIRSE Standards of Practice documents are not intended to impose a standard of clinical patient care, but to recommend a reasonable approach to, and best practices for, procedural performance, in this instance the use of non-sclerosant liquid embolic agents. Methods: The writing group was established by the CIRSE Standards of Practice Committee and consisted of five clinicians with internationally recognised expertise in non-sclerosant liquid embolic agents and a research assistant (P.R.). The writing group reviewed the existing literature on non-sclerosant liquid embolic agents, performing a pragmatic evidence search using PUBMED and EMBASE focussing on English-language publications, preferably from 2009 up to December 2025, and including more than ten patients. Where clear gaps were evident, older literature was searched and select references included. The final recommendations were formulated through consensus. Results: Non-sclerosant liquid embolic agents are represented by cyanoacrylates and polymers which are safe and effective agents that can be used in a wide range of clinical scenarios, resulting in effective embolization even in patients with impaired coagulation function. Knowing their chemical properties provides understanding of their correct preparation, technical application and clinical indication. Compared to mechanical and particulate agents, non-sclerosant liquid embolic agents present a steeper learning curve, and thus, thorough training in their use is essential.
SN - 0174-1551
SN - 1432-086X
ER -